Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study

2017 ◽  
Vol 112 (7) ◽  
pp. 1084-1093 ◽  
Author(s):  
Yen-Feng Wang ◽  
Yung-Tai Chen ◽  
Jiing-Chyuan Luo ◽  
Tzeng-Ji Chen ◽  
Jaw-Ching Wu ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
General Population ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Population Based ◽  
Population Based Study ◽  
First Time

Reply: proton-pump inhibitor use and the risk of first-time ischemic stroke in the general population

2017 ◽  
Vol 283 (3) ◽  
pp. 331-331 ◽  
Author(s):  
T. S. G. Sehested ◽  
M. A. Hlatky ◽  
N. Carlson ◽  
G. H. Gislason
Keyword(s):  
Ischemic Stroke ◽  
General Population ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
First Time

scholarly journals Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study

2017 ◽  
Vol 66 (2) ◽  
pp. 247-253 ◽  
Author(s):  
Shelly L. Gray ◽  
Rod L. Walker ◽  
Sascha Dublin ◽  
Onchee Yu ◽  
Erin J. Aiello Bowles ◽  
...  
Keyword(s):  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Population Based ◽  
Population Based Study ◽  
Dementia Risk

Prevalence and incidence of doctor-diagnosed Dupuytren’s disease: a population-based study

2017 ◽  
Vol 42 (7) ◽  
pp. 673-677 ◽  
Author(s):  
J. Nordenskjöld ◽  
M. Englund ◽  
C. Zhou ◽  
I. Atroshi
Keyword(s):  
General Population ◽  
International Classification Of Diseases ◽  
Population Based ◽  
Dupuytren’S Disease ◽  
Level Of Evidence ◽  
Dupuytren's Disease ◽  
Population Based Study ◽  
Classification Of Diseases ◽  
First Time

The prevalence and incidence of doctor-diagnosed Dupuytren’s disease in the general population is unknown. From the healthcare register for Skåne region (population 1.3 million) in southern Sweden, we identified all residents aged ⩾20 years (on 31 December 2013), who 1998 to 2013 had consulted a doctor and received the diagnosis Dupuytren’s disease (International Classification of Diseases 10th Revision code M720). During the 16 years, 7207 current residents (72% men) had been diagnosed with Dupuytren’s disease; the prevalence among men was 1.35% and among women 0.5%. Of all people diagnosed, 56% had received treatment (87% fasciectomy). In 2013, the incidence of first-time doctor-diagnosed Dupuytren’s disease among men was 14 and among women five per 10,000. The annual incidence among men aged ⩾50 years was 27 per 10,000. Clinically important Dupuytren’s disease is common in the general population. Level of evidence: III

Su1900 Temporal Trends in the Prevalence of Dysphagia and Proton Pump Inhibitor Use Over 15 Years: A Population-Based Study

2013 ◽  
Vol 144 (5) ◽  
pp. S-504-S-505
Author(s):  
Rok Seon Choung ◽  
Giles R. Locke ◽  
Cathy D. Schleck ◽  
Alan R. Zinsmeister ◽  
David A. Katzka ◽  
...  
Keyword(s):  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Temporal Trends ◽  
Population Based ◽  
Population Based Study

Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study

2015 ◽  
Vol 41 (11) ◽  
pp. 1175-1181 ◽  
Author(s):  
Y.-P. Wang ◽  
C.-J. Liu ◽  
T.-J. Chen ◽  
Y.-T. Lin ◽  
C.-P. Fung
Keyword(s):  
Proton Pump Inhibitor ◽  
Liver Abscess ◽  
Proton Pump ◽  
Population Based ◽  
Population Based Study

Prevalence of Myocardial Infarction (MI) in Proton Pump Inhibitor (PPI) Users: An Explorative Population-Based Study

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S1596-S1597
Author(s):  
Mohammed Z. Sheriff ◽  
Mohannad Abou Saleh ◽  
Kamal Khorfan ◽  
Emad Mansoor ◽  
Gregory Cooper
Keyword(s):  
Myocardial Infarction ◽  
Proton Pump Inhibitor ◽  
Proton Pump ◽  
Population Based ◽  
Population Based Study
Sign in / Sign up

Export Citation Format

Share Document